UNSPSC 51293206: Pheniprazine hydrochloride

This classification denotes a monoamine oxidase inhibitor with the molecular formula C9H14N2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5B3OM8452C, chemically known as hydrazine, (.alpha.-methylphenethyl)-, monohydrochloride but more generally known as pheniprazine hydrochloride, which bears US NIH Compound Identifier 5929. Most nations, for tariff and trade purposes, schedule pheniprazine hydrochloride under HS 29280090 and SITC 51486.

As of Q4 2014, PHENIPRAZINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Pheniprazine hydrochloride bears US NLM identifiers UMLS ID C2347502 and NCI Concept Code C73612. SMILES: CC(CNN)C1CCCCC1.CL.

UNSPSC 51293206 Pheniprazine hydrochloride is a Commodity code. The recent state and local activity under this code shows a mismatch between the nominal pharmaceutical product and actual procurement focus: Seminole County, Florida's posted opportunity targets naloxone and safe drug deactivation systems rather than pheniprazine hydrochloride. The opportunity itself spans public health goods — opioid-reversal medications and drug destruction equipment — procured through competitive sealed bidding to support community health initiatives. Issuing bodies under this code appear limited to health departments and county public health agencies rather than a broad mix of state and local jurisdictions.

Seminole County's IFB 60459723LAS, posted on June 30, 2026, with a response deadline of July 26, 2023, requested 1,900 units of naloxone and 800 safe drug deactivation systems annually, delivered quarterly to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with one-year renewal option and was potentially funded through FEMA, introducing federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. Vendors must provide unit pricing for each line item, maintain workers' compensation and commercial general liability insurance, comply with drug-free workplace and E-Verify requirements, and accept a three-month probationary period allowing termination at will. The source shows no additional recent opportunities under this code, no other issuing bodies, and no geographic spread beyond Florida.